Sinopharm And Tianjin Pharmaceutical Sign Strategic Collaboration Agreement
This article was originally published in PharmAsia News
Executive Summary
Sinopharm and Tianjin Pharmaceutical have signed a collaborative agreement whereby Sinopharm will invest in the latter's subsidiary Jinkang Pharmaceutical and jointly forge the nation's antibiotic production base. Sinopharm will support the implementation of Tianjin Pharmaceutical's globalization strategy, while Sinopharm Medicine Holding Tianjin and Tianjin Taiping (Group) will set up a new firm to develop a modernized medical logistics platform. The strategic agreement will facilitate the two companies to improve their innovation capability, integrate resources and reduce purchase and storage costs to enhance their competitiveness and expand market share. (Click here for more - Chinese Language)